WEST CHESTER, Pa., March 22, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring
medical interventions, today announced the pricing of its underwritten public offering of 2,033,899 shares of its common stock at a price to the public of $14.75 per share. In addition, Verrica has